A vaccine considered a frontrunner in the race to protect the global population from COVID-19 has produced a robust immune response in elderly people, the group at highest risk from the disease, according to two people familiar with the finding.
Head of Iran’s National Headquarters for Fighting Coronavirus Alireza Zali said the COVID-19-related restrictions will be intensified in capital Tehran as of next week due to the increasing number of infected and hospitalized cases.
Treatment with the rheumatoid arthritis drug tocilizumab, sold as Actemra, reduces the risk for death among hospitalized patients with severe COVID-19 by about 30%, a study published by JAMA Internal Medicine found.
New Zealand Prime Minister Jacinda Ardern swept to an historic election victory and said she will use her mandate to rebuild an economy battered by the coronavirus pandemic and tackle social inequality.
Adults and children born with heart defects had a lower-than-expected risk of developing moderate or severe COVID-19 symptoms, finds a study of more than 7,000 patients from the congenital heart disease center at Columbia University Vagelos College of Physicians and Surgeons.